| Full Name | Jill Morse |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 245 Raven Road, Ketchum, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235224783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | RPT-698 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jill Morse, P.o. Box 3653, Ketchum, ID 83340 Ph: (208) 726-7246 | Jill Morse, 245 Raven Road, Ketchum, ID 83340 Ph: (208) 726-7246 |
News Archive
The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and 10 for and 3 against (1 abstention) on effectiveness, that data including results from a large, prospective randomized clinical trial demonstrated the safety and effectiveness of AMPLIFY™ rhBMP-2 Matrix for fusions of the lower spine in patients with degenerative disc disease.
The American Medical Group Association announced today that the American Heart Association and American Stoke Association will collaborate on Measure Up/Pressure Down, a national campaign to improve high blood pressure prevention, detection and control, spearheaded by the American Medical Group Foundation, AMGA's nonprofit education and research arm.
Scientists led by Walter Koch, Ph.D., director of the Center for Translational Medicine in the Department of Medicine in Jefferson Medical College of Thomas Jefferson University in Philadelphia, used a virus to insert the gene for a protein called S100A1 into failing rat hearts.
Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that the FDA has granted clearance to proceed with VLX600 into the clinical phase I/II. VLX600 is one of the company's promising projects, and which was recently published in the journal Nature Communications.
Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.
› Verified 8 days ago
Robbin Warner, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Drive, Ketchum, ID 83340 Phone: 208-727-8253 | |
John C Koth, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Saddle Road, Ketchum, ID 83340 Phone: 208-726-9222 Fax: 208-726-1607 | |
Koth Sports Physical Therapy, Pa Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Saddle Road, Ketchum, ID 83340 Phone: 208-726-9222 Fax: 208-726-1607 | |
Dr. Brenna Colleen Rohnkohl, DPT, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Dr #104, Ketchum, ID 83340 Phone: 208-727-8253 | |
Sarah Armstrong, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Way, Suite 104, Ketchum, ID 83340 Phone: 208-727-8253 | |
Katherine Quaglia, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Drive, Suite # 104, Ketchum, ID 83340 Phone: 208-727-8274 |